Alcon (ALC) completes $550M acquisition of Neurotech Pharmaceuticals
FROM THE WIRE · GURUFOCUS.COM
On October 20, 2026, Alcon Inc (NYSE: ALC) announced the completion of its acquisition of Neurotech Pharmaceuticals for $550 million, securing control over Ence
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralMid-sized M&A deal in ophthalmics, with ordinary impact on the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Alcon completed its acquisition of Neurotech Pharmaceuticals.
- 02The deal is valued at $550 million.
- 03The acquisition secures control over Encelto.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets